News Chart Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Delayed Toronto S.E. Other stock markets 03:59:29 2024-05-17 pm EDT			5-day change	1st Jan Change
8.69 ^CAD	-1.47%		-1.47%	+56.86%

May. 13	Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50	MT
May. 10	Transcript : Cipher Pharmaceuticals Inc., Q1 2024 Earnings Call, May 10, 2024

c01698afa52746394b.sahsRxzXe9J4oIpBX2eX8cNzX-tUULRf9fAvjZYAc54.2ZkaAXuiGJgn1bIIMhfPsJosHYZiBfwYoKYc5MJOJPzy6Vp_VJo0uznU6Q~ad10de8fc0e70f81b5110008e3f5efc7